BPCE
AMED

Bank Pictet & Cie (Europe)’s Amedisys AMED Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,873
Closed -$998K – 154
2024
Q2 		$998K Hold
10,873
– – 0.02% 104
2024
Q1 		$1M Hold
10,873
– – 0.03% 108
2023
Q4 		$1.03M Buy
10,873
+382
+4% +$35.7K 0.03% 145
2023
Q3 		$980K Hold
10,491
– – 0.03% 136
2023
Q2 		$959K Hold
10,491
– – 0.03% 145
2023
Q1 		$772K Buy
10,491
+628
+6% +$54.3K 0.03% 116
2022
Q4 		$824K Sell
9,863
-2,787
-22% -$251K 0.04% 109
2022
Q3 		$1.22M Sell
12,650
-2,138
-14% -$255K 0.06% 98
2022
Q2 		$1.55M Sell
14,788
-6,251
-30% -$799K 0.07% 88
2022
Q1 		$3.63M Buy
21,039
+1,340
+7% +$200K 0.14% 73
2021
Q4 		$3.19M Sell
19,699
-2,504
-11% -$402K 0.11% 78
2021
Q3 		$3.31M Buy
22,203
+11,679
+111% +$2.43M 0.12% 78
2021
Q2 		$2.58M Buy
+10,524
New +$2.76M 0.09% 83

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s AMED Position: Q3 2024 in Review

Bank Pictet & Cie (Europe) sold out of Amedisys (AMED) in Q3 2024, closing a stake of 10,873 shares — an estimated $998K sold.

Bank Pictet & Cie (Europe) first reported a position in AMED in Q2 2021 and held it in 13 quarters. The position peaked at $3.63M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Bank Pictet & Cie (Europe) reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 10,873 Amedisys shares in Q3 2024, an estimated $998K.
  • Bank Pictet & Cie (Europe) first reported a position in Amedisys in Q2 2021 and held it in 13 quarters.
  • Bank Pictet & Cie (Europe)'s Amedisys position peaked at $3.63M in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q3 2024, filed 22 Oct 2024.